Procept biorobotics stock.
The 12-month stock price forecast is $43.67, which is an increase of 25.85% from the latest price. Price Target $43.67 ( 25.85% upside) Analyst Consensus: Strong …
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago.Aquablation therapy represents a paradigm shift in the surgical treatment of BPH. By addressing the compromise between safety and efficacy, it delivers effective, safe and …PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, …This Registration Statement on Form S-1 (this "Registration Statement") is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, for the sole purpose of increasing the aggregate number of shares of common stock offered by PROCEPT BioRobotics Corporation (the “Registrant”) by 1,214,400 shares, 158,400 of which are …Procept BioRobotics stock rises as B Riley starts coverage with buy rating, $53 PT SA News Thu, Jun. 23, 2022. Procept BioRobotics gets additional positive coverage policies for prostate gland ...
The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...
Nov 1, 2023 · SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023. PROCEPT BioRobotics Stock Up 4.0 % Shares of NASDAQ PRCT opened at $33.91 on Monday. The company has a current ratio of 6.40, a quick ratio of 5.21 and a debt-to-equity ratio of 0.34.
Verdict: PROCEPT BioRobotics lost $1.96 a share on $75 million worth of revenue in FY2022. The current analyst firm consensus has that loss expanding a bit in FY2023 to $2.13 a share even as sales ...PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.
Main Lobby Procept BioRobotics Main Lobby Main Entrance Procept BioRobotics Main Entrance SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT ...
PROCEPT BioRobotics Corporation reported 135% YoY Q3 revenue growth to $20.3mm. Growth was underscored by robotic system sales and utilization from current placements. ... The stock has climbed 74 ...
Key Insights. Significantly high institutional ownership implies PROCEPT BioRobotics' stock price is sensitive to their trading actions. 51% of the business is held by the top 8 shareholdersPROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23.PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell …NASDAQ: PRCT. $34.69. Nov 29, 2023 10:22 AM EST. Change. +0.92 (+2.72%) Volume. 50,583. Today's Open. $34.34.REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2022. Recent …Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level …REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...
Procept Biorobotics Corp does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Procept Biorobotics Corp’s trailing 12-month revenue is $116.4 million with a -89.8% profit margin. Year-over-year quarterly sales growth most recently was 98.2%.The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math.Dec 2, 2023 · Procept BioRobotics Corp (PRCT) registered a 0.78% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.78% in intraday trading to $37.36 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is 5.69%, and it has moved by 35.61% in 30 days. Nov 9, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 17.51% so far this month. During the month of November, Procept Biorobotics Corp’s stock price has reached a high of $35.00 and a low of $26.44. Over the last year, Procept Biorobotics Corp has hit prices as high as $47.75 and as low as $24.83 ... PROCEPT BioRobotics has raised $348.84M over 8 rounds. PROCEPT BioRobotics's latest funding round was a IPO for $163.9M on September 15, 2021. PROCEPT BioRobotics's latest post-money valuation is from September 2021. Sign up for a free demo to see PROCEPT BioRobotics's valuations in September 2021 and more. …
The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math.
REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023.Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. The latest price target for PROCEPT BioRobotics ( NASDAQ: PRCT) was reported by Leerink Partners on Monday, October 16, 2023. The analyst firm set a price target for 37.00 expecting PRCT to rise ...Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 10.07% so far this month. During the month of May, Procept Biorobotics Corp’s stock price has reached a high of $34.48 and a low of $26.66. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.29. Year to ...PROCEPT BioRobotics also completed an equity follow-on offering, raising $162 million in net proceeds, and received FDA IDE approval for Aquablation Therapy for Prostate Cancer. PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance | PRCT Stock NewsUnderstanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.
Oct 25, 2023 · PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
Nov 1, 2023 · SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023. REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...PROCEPT BioRobotics also expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock. The …Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s ( PRCT) price is currently down 7.58% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $34.37. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $21.90.PROCEPT BioRobotics will host a conference call to discuss the second quarter 2022 financial results after the market close on Thursday, August 4th, 2022, at 1:30 p.m. Pacific Time / 4:30 p.m ...PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with …Main Lobby Procept BioRobotics Main Lobby Main Entrance Procept BioRobotics Main Entrance SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT ...SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023. Recent …REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...
One other stock in the same industry, PROCEPT BioRobotics Corporation PRCT, finished the last trading session 4.5% lower at $26.94. PRCT has returned -15% over the past month. PRCT has returned ...Over the past fifty days, PROCEPT BioRobotics’ stock displayed stability as evidenced by its average price holding steady at $34.40 based on moving averages calculations by experts in this field.. Furthermore, over a longer duration of time spanning two hundred days previous to September 1st ,2023 ,the stock maintained an average …SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23.31 พ.ค. 2566 ... Stock ratings and valuation methodologies: William Blair & Company, L.L.C. uses a three-point system to rate stocks. Individual ratings reflect ...Instagram:https://instagram. draftkings legal in floridausda fixer upper loanmovavax stockrio tinto dividends Nov 1, 2023 · SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ... Procept wrote in a revised S-1 filing with the U.S. Securities and Exchange Commission that it intends to offer 5.5M shares of its stock at an expected $22-$24/range. The company is also granting ... hiltonstockhow much is gold bars Nov 1, 2023 · SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023. nysearca xlv According to 4 analyst offering 12-month price targets in the last 3 months, PROCEPT BioRobotics has an average price target of $49.75 with a high of $58.00 and a low of $44.00. Below is a summary ...PROCEPT BioRobotics Corp PRCT Morningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...